← FDA DRUG APPROVALS

FDA ANDA · ANDA086077

NITROFURAZONE

Sponsor: AMBIX

APPLICATION
ANDA086077
TYPE
ANDA
ORIGINAL APPROVAL
1978-04-26
LATEST ACTION
1985-09-12
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

NITROFURAZONEDiscontinued
NITROFURAZONE 0.2% · OINTMENT · TOPICAL

Approval history

1985-09-12Manufacturing (CMC) · Supplement 2AP
1978-04-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →